Guide · ADHD
What is ADHD, and how is it diagnosed in Australia?
ADHD stands for attention deficit hyperactivity disorder. It is a neurodevelopmental condition, meaning it comes from differences in how the brain develops, and it affects attention, activity levels and impulse control. Here is what it is, how common it is, what causes it, and how diagnosis and treatment work in Australia.
Updated 5 October 2026 · About 11 minutes to read · All guides
In short
- ADHD stands for attention deficit hyperactivity disorder: a neurodevelopmental condition in which inattention, hyperactivity or impulsivity are persistent, start in childhood and get in the way of daily life.
- It has two symptom groups, inattention and hyperactivity-impulsivity, and three presentations: predominantly inattentive, predominantly hyperactive-impulsive, and combined.
- Worldwide, about 5% to 7% of children and about 2.5% of adults have ADHD. Australia's national child survey found 7.4% of 4 to 17 year olds met criteria.
- ADHD is strongly genetic: across 37 twin studies, about 74% of the variation in ADHD traits was inherited. Sugar, screens and parenting have not been shown to cause it.
- In Australia, ADHD is diagnosed by paediatricians, psychiatrists and psychologists, working to the 2022 national guideline; treatment usually combines medication with psychological support.
What ADHD is
ADHD stands for attention deficit hyperactivity disorder. In plain words, it is a condition where a person finds it much harder than most people their age to hold attention, sit with boredom, organise themselves, or stop and think before acting. Everyone has moments like that; in ADHD they are frequent, long-standing and get in the way of school, work or relationships.
Formally, ADHD is a neurodevelopmental condition: Healthdirect describes it as a brain development condition that begins in early childhood.
The formal definition
Clinicians diagnose ADHD against one of two manuals: the DSM-5-TR, the American Psychiatric Association's manual, or the World Health Organization's ICD-11, where ADHD has the code 6A05. As summarised by the APA and the US Centers for Disease Control and Prevention, the DSM criteria require:
- at least six symptoms of inattention and/or six of hyperactivity-impulsivity for children up to 16, or five for people aged 17 and over, lasting at least six months
- several symptoms present before age 12
- symptoms in two or more settings, such as home and school
- clear evidence that the symptoms interfere with social, school or work life
- symptoms not better explained by another condition
So ADHD is defined by impact, not traits alone, and because symptoms must date from childhood, an adult assessment still looks back at the school years (see ADHD in adults).
The two symptom groups, and the three types of ADHD
ADHD symptoms fall into two groups. Inattention is about focus, organisation and follow-through. Hyperactivity-impulsivity is about restlessness and acting before thinking. They look different in a seven year old and a 37 year old.
| Symptom group | In children | In adults |
|---|---|---|
| Inattention | Not finishing tasks, easily distracted, not seeming to listen, trouble remembering and organising, losing things, avoiding anything that needs sustained effort | Trouble managing time and staying organised, running late, procrastinating, difficulty following conversations, mind-wandering |
| Hyperactivity-impulsivity | Fidgeting and squirming, leaving their seat, running or climbing at the wrong times, talking non-stop, blurting out answers, trouble waiting, interrupting | Feeling restless and unable to relax, talking excessively or interrupting, excessive spending, risk-taking, reacting quickly without thinking |
In adults, the APA notes, hyperactivity and impulsivity may fade or become extreme restlessness, while inattention tends to persist.
The three presentations
Depending on which group dominates, ADHD has one of three presentations, the manual's word for types:
- Predominantly inattentive: enough inattention symptoms, but not enough hyperactive-impulsive ones. This is what most people mean by "ADD".
- Predominantly hyperactive-impulsive: the reverse.
- Combined: enough symptoms in both groups.
A 2012 meta-analysis of 86 studies found the inattentive presentation is the most common in the general population, while the combined presentation is more often referred to clinics. See ADD vs ADHD on whether "ADD" still exists, and ADHD in women and girls on why inattentive symptoms get missed.
How common is ADHD?
Estimates move with the criteria and methods used, but the large reviews agree:
- A 2012 meta-analysis of 86 studies (163,688 children and adolescents) found 5.9% to 7.1% whether ADHD was rated by parents, teachers or clinicians.
- The World Federation of ADHD's 2021 international consensus statement puts it at 5.9% of young people and 2.5% of adults, at similar rates across continents.
ADHD in Australia
The main Australian source is Young Minds Matter, the second national child and adolescent mental health survey, which interviewed the parents or carers of 6,310 children aged 4 to 17 in 2013–14. It found that 7.4% had ADHD in the previous 12 months, the most common mental disorder in that age group, ahead of anxiety disorders at 6.9%. The Australian Institute of Health and Welfare reports 8.2% among 4 to 11 year olds, and 11% among boys of that age. Healthdirect's rounder figure is about 1 in 20 Australians. Treatment is rising: PBS prescriptions for ADHD medicines grew just under 18% a year on average from 2013–14, and adults were half of new patients in 2022–23.
Adults
A 2021 global meta-analysis of 40 studies from 30 countries estimated that 2.58% of adults have persistent ADHD, meaning it began in childhood, and 6.76% have symptomatic adult ADHD when childhood onset is not required; both fell with age. No Australian study has measured adult ADHD with current criteria; the national guideline expects 2% to 6%.
What causes ADHD?
Nobody chooses ADHD, and nobody causes it in their child. It is mostly inherited, brain development follows a somewhat different timetable, and a few early-life factors add risk.
Genes
A 2019 review in Molecular Psychiatry found that across 37 twin studies, the average heritability of ADHD and of inattention and hyperactivity traits was 74%: about three quarters of the variation between people traces back to genes. There is no single ADHD gene; about a third of that heritability comes from many common variants with tiny individual effects, plus some rare deletions and insertions of DNA.
Brain development
The largest brain imaging study so far pooled MRI scans of 1,713 people with ADHD and 1,529 without, aged 4 to 63, and found slightly smaller volumes in several deep brain structures involved in reward, emotion, memory and movement. The differences were small, most marked in children and faded in adults, which fits the idea that brain maturation in ADHD is delayed rather than permanently different. They are group averages: the consensus statement says they cannot be used to diagnose ADHD, so a brain scan cannot tell you whether you or your child has it.
Pregnancy and birth
The Australian guideline lists early-life factors linked with higher rates of ADHD: prenatal exposure to lead, maternal smoking and the epilepsy medicine valproate, very preterm birth (before 32 weeks), low birth weight, and psychosocial adversity. The consensus statement reports about three times the rate of ADHD in very preterm or very low-birth-weight babies, and around four times the odds with higher blood lead. Many of these links shrink or disappear once family history is taken into account (the smoking link disappears after adjusting for ADHD in the family), so the statement calls them correlates, not causes.
What does not cause ADHD
- Sugar. A meta-analysis of 23 controlled studies in JAMA found that sugar does not affect children's behaviour or thinking, though a small effect in some children could not be ruled out.
- Screens. A 2014 meta-analysis of 45 studies found only a small statistical link between media use and ADHD-type behaviours (a correlation of 0.12), and such studies cannot show which way the link runs; restless, distractible children may simply use screens more.
- Parenting. The ADHD Evidence Project, which curates the research behind the consensus statement, lists "poor parenting" among the myths: many parents of children with ADHD have ordinary parenting skills, and parenting programs, while helpful, do not make ADHD go away. Family stress can make symptoms harder to live with; that is different from causing them.
Conditions that often come with ADHD
ADHD rarely travels alone. Australia's guideline says around two-thirds of children with ADHD have a co-occurring mental health or developmental condition, most often oppositional defiant disorder (a persistent pattern of angry, defiant behaviour), anxiety, learning disorders, autism and tics. In a Danish study of 14,825 children and teenagers diagnosed in hospital clinics, 52% had at least one other psychiatric diagnosis: conduct and oppositional disorders (16.5%), developmental disorders of language, learning or movement (15.4%), autism (12.4%) and intellectual disability (7.9%) were the most frequent. Clinic samples pick up more complex cases, so community rates are likely lower.
Healthdirect adds anxiety, depression, learning difficulties and obstructive sleep apnoea (the airway being blocked during sleep). For adults the guideline's figure is up to 80%; see ADHD in adults.
A good assessment looks for these conditions because they change what support is needed, and because anxiety, sleep problems and learning difficulties can look like ADHD on their own. When autism and ADHD both fit, see what AuDHD means.
How ADHD is diagnosed and treated in Australia
Who can diagnose ADHD
Healthdirect lists paediatricians, psychiatrists and psychologists as the professionals who diagnose ADHD, and your GP can refer you. Some GPs with extra training can also diagnose and, in NSW, start medication. Rules differ by state and are changing; see our ADHD assessment page.
What an assessment should include
Since 2022 Australia has had its own guideline, the Australian Evidence-Based Clinical Practice Guideline for ADHD, from the Australasian ADHD Professionals Association (AADPA). It says the assessment should include a full clinical and psychosocial assessment, a developmental, mental health and medical history, reports from other people, and a medical check to exclude other causes, and that the clinician must confirm the symptoms meet the criteria, cause significant impairment and occur in two or more settings.
Questionnaires are part of this, not the whole of it. The most used adult screener, the World Health Organization's Adult ADHD Self-Report Scale (ASRS), has a six-question short form that in a US national survey identified about 69% of adults with ADHD and correctly cleared 99.5% of those without. A positive screen is a reason to look further, not a diagnosis. Our free ADHD test uses those six questions (the ASRS guide explains the scoring); for children, see ADHD in children.
How ADHD is treated
The guideline recommends multimodal treatment: medication and non-medication supports together. For children it recommends parent and family training, and for adolescents cognitive behavioural therapy (CBT); Healthdirect lists CBT for adults too.
On medication, the guideline recommends a stimulant (methylphenidate, dexamfetamine or lisdexamfetamine) first, with the non-stimulants atomoxetine or guanfacine when stimulants are unsuitable or do not work, and caution in children under five. The main evidence is a 2018 network meta-analysis in The Lancet Psychiatry of 133 double-blind randomised trials in 14,346 children and adolescents and 10,296 adults. At around 12 weeks, on clinicians' ratings every medicine studied beat placebo in children and most did in adults, though long-term evidence is lacking. In Australia the stimulants are Schedule 8 controlled medicines, prescribed only by doctors with special approval under state and territory rules, and the main ADHD medicines are subsidised on the PBS. Our ADHD medication guide covers each medicine, its side effects and the rules.
ADHD and neurodivergence
Alongside the medical definition, many people describe ADHD as a form of neurodivergence: a brain that works differently from the majority, with real difficulties in some settings and real strengths in others. The Raising Children Network uses similar language, calling ADHD a natural variation in the way the brain processes information. The two framings are not in conflict: the diagnosis exists because the difficulties are real and naming them opens the door to treatment and adjustments, and the neurodivergence framing is a reminder that the person is not broken. See what neurodivergent means and is ADHD a disability?
The free screener is a reasonable first step. It cannot diagnose anyone, and an assessment can conclude ADHD, not ADHD, or something else.
Questions people ask
What does ADHD stand for?
ADHD stands for attention deficit hyperactivity disorder. It is a neurodevelopmental condition, diagnosed when inattention and/or hyperactivity-impulsivity are persistent, began in childhood and interfere with daily life. The older label ADD is not used in the current manuals; what it described is now the predominantly inattentive presentation.
What are the 3 types of ADHD?
The DSM-5-TR describes three presentations: predominantly inattentive, predominantly hyperactive-impulsive, and combined, with enough symptoms in both groups. A 2012 meta-analysis found the inattentive presentation is the most common in the general population, while the combined presentation is more often seen in clinics.
What are the main symptoms of ADHD?
Inattention symptoms include being easily distracted, not finishing tasks, losing things and avoiding anything that needs sustained effort. Hyperactive-impulsive symptoms include fidgeting, talking non-stop, blurting out answers, trouble waiting and interrupting. Children need six symptoms from a group and people aged 17 and over need five, with several present before age 12 and in two or more settings.
Is ADHD a mental illness or a disability?
Both the DSM-5-TR and the ICD-11 classify ADHD as a neurodevelopmental disorder, alongside autism and learning disorders. Whether it counts as a disability depends on the setting and how much it affects the person, and it does not appear on the NDIS access lists on its own. See is ADHD a disability?
Is ADHD genetic?
Largely, yes. Across 37 twin studies the average heritability of ADHD and ADHD traits was 74%, and Australia's ADHD guideline gives 70% to 80%. There is no single ADHD gene; many common variants with tiny effects add up, and genes raise the odds rather than deciding the outcome.
Can adults have ADHD?
Yes. Many adults are first diagnosed well into adult life. A 2021 global meta-analysis estimated that 2.58% of adults have ADHD that began in childhood and 6.76% have adult ADHD symptoms when childhood onset is not required. Adults need five symptoms from a group rather than six. See ADHD in adults.
Wondering whether an assessment makes sense? The free screener takes about three minutes, for your child, your adult son or daughter, or yourself. It suggests which assessment fits, and it will tell you if one does not look like the right next step. Start the free screener.
Related
ADHD in adults · ADD vs ADHD · ADHD in children · Free ADHD test · ADHD assessment · All guides
Where this information comes from
We would rather you checked us than took our word for it. Every link below is the original source, not a summary of one.
- Healthdirect (2025). Attention deficit hyperactivity disorder (ADHD).Government-funded overview defining ADHD as a neurodevelopmental condition, listing symptoms, risk factors, who diagnoses it, treatments, co-occurring conditions, the 1 in 20 figure and state prescribing laws.
- American Psychiatric Association (2025). What is ADHD?The DSM publisher's summary of the criteria: six symptoms (five from 17), onset before 12, more than one setting, the three presentations, and how hyperactivity may fade or become restlessness in adults.
- Centers for Disease Control and Prevention (2026). Clinical Care of ADHD in Children.US government summary of the DSM-5 criteria: symptom counts by age, six months, several symptoms before 12, two or more settings, interference, not better explained; and the two symptom lists.
- World Health Organization (2024). ICD-11 for Mortality and Morbidity Statistics: 6A05 Attention deficit hyperactivity disorder.The WHO classification entry giving ADHD the code 6A05 and defining it as a persistent pattern of inattention and/or hyperactivity-impulsivity outside normal variation for age with direct negative impact on functioning.
- AADPA (2022). Australian Evidence-Based Clinical Practice Guideline for ADHD: About ADHD.Background chapter of the national guideline covering prevalence in Australia (6% to 10% of children; 2% to 6% of adults internationally), heritability of 70% to 80%, environmental risk factors, presentation by age and co-occurring conditions.
- AADPA (2022). Australian Evidence-Based Clinical Practice Guideline for ADHD: Summary of Recommendations.The national guideline's recommendations on who should assess (2.1.1), what an assessment includes (2.1.2, 2.1.3), co-occurring conditions (2.2.1), multimodal treatment (3.1.1), parent training (4.2.2), CBT for adolescents (4.2.9), and medication (5.2.1, 5.4.1, 5.4.4).
- Young Minds Matter, The Kids Research Institute Australia (2015). Prevalence of mental disorders.Results page of the second Australian Child and Adolescent Survey of Mental Health and Wellbeing: 13.9% of 4 to 17 year olds had a mental disorder in the past 12 months, ADHD 7.4%, anxiety 6.9%.
- Lawrence et al. (2016). Key findings from the second Australian Child and Adolescent Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry.Peer-reviewed report of the Young Minds Matter survey of 6,310 parents and carers of 4 to 17 year olds, in which ADHD was the most common class of disorder.
- Australian Institute of Health and Welfare (2023). Australia's children: Children with mental illness.National statistics agency summary of the 2013–14 survey: ADHD the most common disorder in children aged 4 to 11 (8.2%), and 11% among boys.
- Drug Utilisation Sub-Committee, Department of Health and Aged Care (2023). Analysis of PBS and RPBS listed medicines used in the management of attention deficit hyperactivity disorder.Official review of PBS-listed ADHD medicines (dexamfetamine, methylphenidate, lisdexamfetamine, atomoxetine, guanfacine) and prescription growth of just under 18% a year since 2013–14, with adults half of new patients in 2022–23.
- Willcutt (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics.Meta-analysis of 86 studies of 163,688 children and adolescents finding prevalence of 5.9% to 7.1% regardless of informant, the inattentive presentation most common in the community, and no significant country differences after adjusting for method.
- Song et al. (2021). The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. Journal of Global Health.Meta-analysis of 40 studies from 30 countries estimating persistent adult ADHD at 2.58% and symptomatic adult ADHD at 6.76% in 2020, both falling with age.
- Faraone et al. (2021). The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews.Consensus of 80 authors from 27 countries: ADHD in 5.9% of youth and 2.5% of adults; environmental risk factors as correlates not causes; no link with sugar; brain differences too small to diagnose; stimulants effective.
- Faraone & Larsson (2019). Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry.Review finding a mean heritability of 74% across 37 twin studies, with about a third of heritability from many common variants of small effect and part from rare insertions and deletions.
- Hoogman et al. (2017). Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. The Lancet Psychiatry.ENIGMA imaging study of 1,713 people with ADHD and 1,529 controls from 23 sites finding small volume differences in several subcortical structures, most marked in children, supporting delayed brain maturation.
- Wolraich et al. (1995). The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA.Meta-analysis of 23 within-subject studies finding sugar does not affect children's behaviour or cognitive performance, while a small effect in subsets could not be ruled out.
- Nikkelen et al. (2014). Media use and ADHD-related behaviors in children and adolescents: A meta-analysis. Developmental Psychology.Meta-analysis of 45 studies finding a small correlation (r = 0.12) between media use and ADHD-related behaviours, which cannot establish cause or direction.
- ADHD Evidence Project (2021). Myths about the cause of ADHD.Evidence-curation project associated with the International Consensus Statement's lead author, setting out why sugar, television and poor parenting are not supported as causes of ADHD.
- Jensen & Steinhausen (2015). Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. ADHD Attention Deficit and Hyperactivity Disorders.Danish register study of 14,825 patients aged 4 to 17 with ADHD: 52% had at least one comorbid psychiatric disorder, 26.2% two or more; conduct disorders 16.5%, developmental disorders 15.4%, autism 12.4%, intellectual disability 7.9%.
- The Royal Children's Hospital Melbourne (2026). Kids Health Information: Attention deficit hyperactivity disorder (ADHD).Hospital fact sheet stating that only trained health professionals can diagnose ADHD in children, including paediatricians, child psychologists, child psychiatrists and some GPs, and that ADHD is closely linked to genetics.
- Raising Children Network. ADHD: attention deficit hyperactivity disorder.Government-funded parenting site describing ADHD as a natural variation in the way the brain processes information, listing signs, and noting the GP may refer to a paediatrician, psychologist or psychiatrist.
- NSW Health. Prescribe a psychostimulant medicine.Confirms dexamfetamine, lisdexamfetamine and methylphenidate are Schedule 8 medicines requiring approval, which specialists hold class authority, and that accredited GPs can now diagnose ADHD and initiate medication in NSW.
- Healthdirect. Scheduling of medicines and poisons.Plain-English definition of Schedule 8 controlled drugs and the rules that apply to prescribing them.
- Healthdirect (2025). ADHD medicines.Government-funded overview of stimulant and non-stimulant ADHD medicines, stimulants as the usual first medicine, tight prescribing controls, and medicine combined with psychological support.
- Cortese et al. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet Psychiatry.Network meta-analysis of 133 double-blind trials (14,346 children and adolescents, 10,296 adults) at about 12 weeks, favouring methylphenidate in children and amphetamines in adults and noting the lack of long-term evidence.
- Kessler et al. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychological Medicine.Development of the ASRS and its six-question screener in the US National Comorbidity Survey Replication: sensitivity 68.7%, specificity 99.5%.
Links to external sites are provided for reference. We do not control them and they may change. Last checked 5 October 2026.
This guide is general information, not medical advice. If you are worried about yourself or your child, talk to your GP.
Not sure where to start?
For your child, your adult son or daughter, or yourself. The free screener takes about three minutes and tells you which assessment fits — or whether you need one at all.